We only have this paper's title and publication details.
Read it at the sourceAnswers are grounded in this paper and cite their sources.
This evaluation demonstrates a biological alternative for coronary artery bypass grafting, suggesting practical implications.
The ATEV-ESS has the potential to provide an off-the-shelf alternative for CABG.
No takes yet. Share an insight, caveat, or question.
Ebner et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: